Introduction
Proton pump inhibitors (PPIs) are among the most commonly used medications for acid reflux, GERD, peptic ulcers, and H. pylori eradication. Omeprazole and pantoprazole are two of the most popular.
What Are PPIs?
PPIs irreversibly inhibit the H+/K+ ATPase enzyme (the proton pump) in stomach parietal cells, reducing acid secretion by up to 90%.
Omeprazole (Prilosec)
Available OTC and by prescription. Typically dosed at 20–40 mg daily. More CYP2C19 interactions than pantoprazole — relevant for patients on clopidogrel.
Pantoprazole (Protonix)
Prescription-only (though generics are available OTC in some regions). Dosed at 40 mg daily. Fewer drug interactions than omeprazole, making it preferable for cardiac patients.
Efficacy Comparison
Both are equally effective for GERD and peptic ulcer healing when used at standard doses. No clear clinical superiority of one over the other.
Drug Interactions
Omeprazole significantly reduces clopidogrel activation — use pantoprazole in patients on this antiplatelet agent. Both can reduce methotrexate levels.
Long-Term Use Considerations
Prolonged PPI use has been associated with vitamin B12 and magnesium deficiency, C. difficile risk, and potential bone density reduction. Use the lowest effective dose for the shortest necessary duration.
Conclusion
Both omeprazole and pantoprazole are effective PPIs. Choice depends primarily on drug interactions and individual patient factors rather than efficacy differences.